Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1

John D Reveille | Michael H Weisman | Linda A Bradbury | Proton Rahman | Paul Bowness | Karl Gaffney | Gilles Chiocchia | Maxime Breban | Henri-Jean Garchon | Jaakko Tuomilehto | Lianne S Gensler | Dirk Elewaut | David M. Evans | L. Bradbury | J. J. Pointon | M. Brown | P. D. de Bakker | D. Gladman | A. Cortes | B. Lie | J. Tuomilehto | J. Reveille | S. Pulit | M. Weisman | D. Evans | P. Rahman | Javier Martín | M. González-Gay | Xiaodong Zhou | F. Pimentel-Santos | L. Gensler | H. Garchon | M. Breban | J. Crusius | P. Bowness | R. Burgos-Vargas | D. Elewaut | P. Leo | C. López-Larrea | W. Maksymowych | F. Blanco | R. Inman | Bryan Paul Wordsworth | J. Nossent | S. Stebbings | I. E. van der Horst-Bruinsma | Robert D Inman | Paul I W de Bakker | Louise Appleton | Javier Martin | David M Evans | Dafna D Gladman | Adrian Cortes | Matthew A Brown | Walter P Maksymowych | Nigil Haroon | Sara L Pulit | Benedicte A Lie | Michael Ward | N. Haroon | P. Robinson | Hill Gaston | Miguel A Gonzalez-Gay | G. Chiocchia | J Bart A Crusius | Francisco J Blanco | Xiaodong Zhou | Øystein Førre | Irene E van der Horst-Bruinsma | Philip C Robinson | Johannes Nossent | Kari Laiho | Ruben Burgos-Vargas | Simon Stebbings | Claire Farrah | Jonathan Lau | Juan Mulero | Raphael Valle-Oñate | Consuelo Romero-Sánchez | Inger Myrnes Hansen | Fernando M Pimentel-Santos | K. Gaffney | J. Mulero | Paul J Leo | Jenny J Pointon | C Lopez-Larrea | Ø. Førre | H. Gaston | C. Romero-Sánchez | K. Laiho | Michael D. Ward | R. Valle-Oñate | I. M. Hansen | L. Appleton | C. Farrah | Jonathan Lau | David M. Evans | David M. Evans

[1]  Matti Pirinen,et al.  A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 , 2010, Nature Genetics.

[2]  R. Colbert,et al.  HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. , 2009, Arthritis and rheumatism.

[3]  A. McMichael,et al.  Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. , 1999, Journal of immunology.

[4]  A Calin,et al.  HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. , 1996, Annals of the rheumatic diseases.

[5]  P Wordsworth,et al.  Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. , 1997, Arthritis and rheumatism.

[6]  D. Heckerman,et al.  Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans. , 2012, Human molecular genetics.

[7]  Paul Weston,et al.  Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility , 2011, Nature Genetics.

[8]  Ruth A. Smith,et al.  Polymorphism at Position 97 in MHC Class I Molecules Affects Peptide Specificity, Cell Surface Stability, and Affinity for β2-Microglobulin1 , 2002, The Journal of Immunology.

[9]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[10]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[11]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[12]  M. Brown,et al.  Immunopathogenesis of ankylosing spondylitis , 2013 .

[13]  R. Inman,et al.  Co‐expression of HLA‐B7 and HLA‐B27 alleles is associated with B7‐restricted immunodominant responses following influenza infection , 2013, European journal of immunology.

[14]  D. M. van der Heijde,et al.  Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis , 2012, Annals of the rheumatic diseases.

[15]  M. Brown,et al.  Promise and pitfalls of the Immunochip , 2011, Arthritis research & therapy.

[16]  L. Bradbury,et al.  Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis , 2014, Genes and Immunity.

[17]  R. Colbert,et al.  HLA-B27 Misfolding in Transgenic Rats Is Associated with Activation of the Unfolded Protein Response1 , 2005, The Journal of Immunology.

[18]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[19]  M. Kiuchi,et al.  Behçet disease and the HLA system. , 2008, Tissue antigens.

[20]  C. Buckley,et al.  The critical role of interleukin-23 in spondyloarthropathy. , 2014, Molecular immunology.

[21]  J. Algayres,et al.  [Skeletal manifestations in Behçet's disease. A report of 79 cases]. , 2008, La Revue de medecine interne.

[22]  C. Tsai,et al.  HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. , 2004, Rheumatology.

[23]  Dean R. Madden,et al.  The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.

[24]  Michael M. Ward,et al.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci , 2010, Nature Genetics.

[25]  Robert M. Plenge,et al.  Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis , 2011, Nature Genetics.

[26]  S Kunmartini,et al.  HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. , 1997, The Journal of rheumatology.

[27]  J. Fernández-Morera,et al.  Association of ankylosing spondylitis with HLA-B*1403 in a West African population. , 2002, Arthritis and rheumatism.

[28]  Wolfram Saenger,et al.  Structural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 Antigens* , 2009, The Journal of Biological Chemistry.

[29]  R D Sturrock,et al.  Ankylosing spondylitis and HL-A 27. , 1973, Lancet.

[30]  S. Kaddouri,et al.  Les manifestations articulaires de la maladie de Behçet . À propos de 79 cas Skeletal manifestations in Behçet ’ s disease . A report of 79 cases , 2008 .

[31]  S. Raimondo,et al.  Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation , 2013, Annals of the rheumatic diseases.

[32]  Simon C. Potter,et al.  Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants , 2007, Nature Genetics.

[33]  Jack T Stapleton,et al.  The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.

[34]  C. Streutker,et al.  HLA-B27, but Not HLA-B7, Immunodominance to Influenza Is ERAP Dependent , 2014, The Journal of Immunology.

[35]  R. Hammer,et al.  Experimental Spondyloarthropathy in HLA-B27 Transgenic Rats , 2013, Clinical Rheumatology.

[36]  Peter Donnelly,et al.  Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci , 2013, Nature Genetics.

[37]  B. Suarez-Alvarez,et al.  The amino acid at position 97 is involved in folding and surface expression of HLA-B27. , 2006, International immunology.

[38]  A. Goldberg,et al.  The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P I Terasaki,et al.  High association of an HL-A antigen, W27, with ankylosing spondylitis. , 1973, The New England journal of medicine.

[40]  A. Cats,et al.  HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. , 1989, Arthritis and rheumatism.

[41]  L. Wedderburn,et al.  Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. , 2005, Arthritis and rheumatism.

[42]  P. Parham,et al.  HLA-B27 and disease: a consequence of inadvertent antigen presentation? , 1992, Rheumatic diseases clinics of North America.

[43]  Akira Meguro,et al.  Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1 , 2013, Nature Genetics.

[44]  Elaine C. Campbell,et al.  Expression of MHC class I dimers and ERAP1 in an ankylosing spondylitis patient cohort , 2011, Immunology.

[45]  B. Suarez-Alvarez,et al.  Influence of HLA-B*5703 and HLA-B*1403 on Susceptibility to Spondyloarthropathies in the Zambian Population , 2008, The Journal of Rheumatology.

[46]  L. Schomburg,et al.  Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum , 2005, Nature Immunology.

[47]  C. Carcassi,et al.  Relevance of residue 116 of HLA‐B27 in determining susceptibility to ankylosing spondylitis , 1995, European journal of immunology.

[48]  D. James,et al.  Human Lymphocyte Antigen Association in Ankylosing Spondylitis , 1973, Nature.